BeStock  
Markets › Compare › EPRX vs NGNE

EPRX vs NGNE

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
EPRX · Eupraxia Pharmaceuticals$5.80 ▼ 5.23%
NGNE · Neurogene$22.15 ▼ 3.40%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

72109145181217Nov 24, '25May 26, '26Nov 20, '26
  • EPRX -6.5%
  • NGNE +8.4%

Head to head

MetricEPRXNGNE
Price$5.80$22.15
Change today▼ 5.23%▼ 3.40%
Market cap$390.16M$458.53M
Return, 3 months-20.3%-44.1%
Return, year to date-23.2%+7.5%
Return, 1 year-6.6%+10.4%
P/E (TTM)––
P/B4.31.3
P/E percentile vs own 5y12th45th
Dividend yield––
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)-139.4%-38.5%
Gross margin––
Operating margin––
Net margin––
Return on equity-78.9%-38.4%
Analyst target vs. price+197.4%+309.3%
Analyst buy share100%100%
RSI (14)3535
30-day volatility83.1%88.8%
Max drawdown, 1 year-36.3%-49.7%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • NGNE is the largest of the group by market value.
  • NGNE has returned the most over the past year.
  • EPRX has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top